Humana (HUM) EBITDA (2009 - 2026)

Humana's EBITDA history runs 18 years deep, the most recent figure standing at $1.9 billion for Q1 2026.

• In Q1 2026, EBITDA fell 12.51% year-over-year to $1.9 billion; the TTM figure through Mar 2026 stood at $3.2 billion (down 24.21% YoY), while the FY2025 annual figure was $3.5 billion, changed 0.2% from the prior year.
• EBITDA was $1.9 billion for Q1 2026 at Humana, up from -$622.0 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $2.2 billion in Q1 2025 to a low of -$622.0 million in Q4 2025.
• Historically, EBITDA has averaged $1.1 billion across 5 years, with a median of $1.4 billion in 2024.
• The sharpest annual moves came in 2022 and 2024: EBITDA soared 969.29% in 2022, then plunged 151.59% in 2024.
• A 5-year view of EBITDA shows it stood at $318.0 million in 2022, then plunged by 139.62% to -$126.0 million in 2023, then slumped by 151.59% to -$317.0 million in 2024, then plunged by 96.21% to -$622.0 million in 2025, then soared by 411.41% to $1.9 billion in 2026.
• The last three EBITDA figures came in at $1.9 billion (Q1 2026), -$622.0 million (Q4 2025), and $591.0 million (Q3 2025), per Business Quant data.